Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study.
Jessica J P ShamiJiaxi ZhaoSwathi PathadkaEric Yuk Fai WanJoseph Edgar BlaisPareen VoraMontse Soriano-GabarróKa Shing CheungW K LeungIan C K WongEsther W ChanPublished in: BMJ open (2022)
In this cohort study of Chinese adults, patients prescribed low-dose aspirin had reduced risks of CRC and GC and an increased risk of GIB. Among the subgroup of patients prescribed gastroprotective agents at baseline, however, the association with GIB was attenuated.
Keyphrases
- low dose
- cardiovascular disease
- end stage renal disease
- ejection fraction
- chronic kidney disease
- type diabetes
- squamous cell carcinoma
- clinical trial
- metabolic syndrome
- young adults
- antiplatelet therapy
- risk assessment
- acute coronary syndrome
- mass spectrometry
- percutaneous coronary intervention
- atrial fibrillation
- study protocol
- papillary thyroid
- cardiovascular risk factors
- patient reported
- liquid chromatography
- tandem mass spectrometry
- childhood cancer